Scientific research company
Headquarters: Brussels, BelgiumUCB is a multinational biopharmaceutical company headquartered in Brussels, Belgium. UCB is an international company with a revenue of €4.178 billion in 2016 which focuses primarily on research and development, specifically involving medications centered on epilepsy, Parkinson's, and Crohn's diseases.
Subsidiaries: UCB, Inc., Ra Pharmaceuticals, Inc., MORE
CEO: Jean-Christophe Tellier (Jan 1, 2015–)